Salathé, Cécile
Poli, Elettra
Altarelli, Marco
Bianchi, Nathan Axel
Schneider, Antoine Guillaume http://orcid.org/0000-0003-0576-7094
Article History
Received: 20 August 2020
Accepted: 9 March 2021
First Online: 19 March 2021
Declarations
:
: The study protocol was approved by the Ethics Committee Vaud (CER-VD 2019–00359). The need to obtain informed consent was waived for patients who were dead at the time of the study unless they had expressed their refusal to have data reutilized, as allowed by Article 34 of the human research act (HRA) of the Swiss regulation. Eligible survivors were sent a written description of the study by regular mail. They were contacted by phone, about 10 days later to obtain consent and administer the survey. The need for written consent was waived by the Ethics committee, on the grounds that the study was considered to be associated with a low-risk and that it appeared disproportionate to ask elderly patients to come to a face-to-face meeting for a 10 min interview. Patients’ consent or refusal were documented in an oral consent form kept in the investigator site file.
: Not applicable.
: CS, MA, NB and EP stated that they had no conflicts of interest to declare.AGS has received a grant from the Leenaards foundation, speaker honoraria from Fresenius Medical Care and consulting honoraria from B Braun Melsungen AG.